CytomX Therapeutics, Inc. (CTMX) earnings
CTMX earnings moved a median of -0.71% by the close. Quarterly and annual CTMX reports and results, each read against the price at its own news timestamp. Back to the CTMX overview →
28 measured CTMX earnings events.
Where these CTMX earnings landedvs 28 measured CTMX earnings reactions
| Middle 50% of CTMX earnings reactions | -4.74% to +5.04% |
|---|---|
| Median reaction (to close) | -0.71% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 CTMX earnings events with a measured close landed between -4.74% and +5.04%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q CytomX Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.60% | +4.22% | |
| CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026 | Press release | +1.10% | +3.15% | |
| Form 10-Q CytomX Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.98% | -1.49% | |
| CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026 | Press release | -0.24% | +3.18% | |
| Form 10-K CytomX Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -6.20% | -2.74% | |
| CytomX Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update | Press release | -4.74% | -4.74% | |
| Form 10-Q CytomX Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -4.74% | -4.74% | |
| CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025 | Press release | -0.77% | +2.46% | |
| CytomX Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update | Press release | +2.93% | +14.63% | |
| Form 10-Q CytomX Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.93% | +14.63% | |
| CytomX Therapeutics to Report Second Quarter 2025 Financial Results on August 7, 2025 | Press release | -3.77% | -8.37% | |
| CytomX Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update | Press release | +5.26% | +12.11% | |
| Form 10-Q CytomX Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +5.26% | +12.11% | |
| CytomX Therapeutics to Report First Quarter 2025 Financial Results on May 12, 2025 | Press release | -0.81% | +9.53% | |
| Form 10-K CytomX Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.38% | -6.35% | |
| CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | +0.00% | -5.22% | |
| Form 10-Q CytomX Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -5.22% | |
| CytomX Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024 | Press release | -0.98% | -1.42% | |
| CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | +1.68% | +0.84% | |
| Form 10-Q CytomX Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.68% | +0.84% | |
| CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024 | Press release | -0.71% | -4.29% | |
| CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | -8.43% | -25.27% | |
| Form 10-Q CytomX Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -8.43% | -25.27% | |
| CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024 | Press release | -6.46% | +57.85% | |
| Form 10-K CytomX Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.00% | +7.50% | |
| CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update | Press release | +0.00% | -3.10% | |
| Form 10-Q CytomX Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -3.10% | |
| CytomX Therapeutics to Report Third Quarter 2023 Financial Results on November 7, 2023 | Press release | — | +0.00% |
Keep exploring
More CTMX: analyst actions → · SEC filings → · CTMX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CONMED Corporation (CNMD) | 268 | -0.11% | 47% |
| Codexis, Inc. (CDXS) | 267 | 0.00% | 51% |
| Galapagos NV - American Depositary Shares (GLPG) | 267 | -0.05% | 44% |
| Eyenovia, Inc. (EYEN) | 266 | -0.95% | 38% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.